Delphine Meynard

Toulouse, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic mice.

A human anti-matriptase-2 antibody limits iron overload, α-globin aggregates, and splenomegaly in β-thalassemic mice.

Journal: Blood advances

Published: October 25, 2023

ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity.

ATGL-dependent white adipose tissue lipolysis controls hepatocyte PPARα activity.

Journal: Cell reports

Published: February 04, 2022

Endoplasmic reticulum stress controls iron metabolism through TMPRSS6 repression and hepcidin mRNA stabilization by RNA-binding protein HuR.

Endoplasmic reticulum stress controls iron metabolism through TMPRSS6 repression and hepcidin mRNA stabilization by RNA-binding protein HuR.

Journal: Haematologica

Published: July 25, 2020

LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA.

LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA.

Journal: Haematologica

Published: December 07, 2019

Regulators of hepcidin expression.

Regulators of hepcidin expression.

Journal: Vitamins and hormones

Published: February 26, 2019

Deletion of BMP6 worsens the phenotype of HJV-deficient mice and attenuates hepcidin levels reached after LPS challenge.

Deletion of BMP6 worsens the phenotype of HJV-deficient mice and attenuates hepcidin levels reached after LPS challenge.

Journal: Blood

Published: July 10, 2017

Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B.

Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B.

Journal: Blood

Published: December 02, 2016

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.

Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice.

Journal: Blood

Published: November 12, 2015

Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.

Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin.

Journal: Hepatology (Baltimore, Md.)

Published: May 13, 2015

MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription.

MicroRNA-130a is up-regulated in mouse liver by iron deficiency and targets the bone morphogenetic protein (BMP) receptor ALK2 to attenuate BMP signaling and hepcidin transcription.

Journal: The Journal of biological chemistry

Published: July 09, 2014

The role of TMPRSS6/matriptase-2 in iron regulation and anemia.

The role of TMPRSS6/matriptase-2 in iron regulation and anemia.

Journal: Frontiers in pharmacology

Published: March 17, 2014

The liver: conductor of systemic iron balance.

The liver: conductor of systemic iron balance.

Journal: Blood

Published: November 09, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026